Wellington Management Group LLP Sigilon Therapeutics, Inc. Transaction History

Wellington Management Group LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.42 - $10.61 $2.74 Million - $6.59 Million	-620,713 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.15 - $20.17 $2.03 Million - $4.47 Million	221,675 Added 55.55%	620,713 $6.66 Million
Q1 2021 May 17, 2021	SELL	$18.76 - $40.91 $1.78 Million - $3.88 Million	-94,725 Reduced 19.18%	399,038 $8.92 Million
Q4 2020 Feb 12, 2021	BUY	$27.6 - $48.03 $13.6 Million - $23.7 Million	493,763 New	493,763 $23.7 Million

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.